Evaluation of A2BP1 as an Obesity Gene by Ma, Lijun et al.
Evaluation of A2BP1 as an Obesity Gene
Lijun Ma,
1 Robert L. Hanson,
1 Michael T. Traurig,
1 Yunhua L. Muller,
1 Bakhshish P. Kaur,
1
Jessica M. Perez,
1 David Meyre,
2 Mao Fu,
3 Antje Ko ¨rner,
4 Paul W. Franks,
5 Wieland Kiess,
4
Sayuko Kobes,
1 William C. Knowler,
1 Peter Kovacs,
6 Philippe Froguel,
2 Alan R. Shuldiner,
3
Clifton Bogardus,
1 and Leslie J. Baier
1
OBJECTIVE—A genome-wide association study (GWAS) in
Pima Indians (n  413) identiﬁed variation in the ataxin-2
binding protein 1 gene (A2BP1) that was associated with percent
body fat. On the basis of this association and the obese pheno-
type of ataxin-2 knockout mice, A2BP1 was genetically and
functionally analyzed to assess its potential role in human
obesity.
RESEARCH DESIGN AND METHODS—Variants spanning
A2BP1 were genotyped in a population-based sample of 3,234
full-heritage Pima Indians, 2,843 of whom were not part of the
initial GWAS study and therefore could serve as a sample to
assess replication. Published GWAS data across A2BP1 were
additionally analyzed in French adult (n  1,426) and children
case/control subjects (n  1,392) (Meyre et al. Nat Genet
2009;41:157–159). Selected variants were genotyped in two addi-
tional samples of Caucasians (Amish, n  1,149, and German
children case/control subjects, n  998) and one additional
Native American (n  2,531) sample. Small interfering RNA was
used to knockdown A2bp1 message levels in mouse embryonic
hypothalamus cells.
RESULTS—No single variant in A2BP1 was reproducibly asso-
ciated with obesity across the different populations. However,
different variants within intron 1 of A2BP1 were associated with
BMI in full-heritage Pima Indians (rs10500331, P  1.9  10
7)
and obesity in French Caucasian adult (rs4786847, P  1.9 
10
10) and children (rs8054147, P  9.2  10
6) case/control
subjects. Reduction of A2bp1 in mouse embryonic hypothalamus
cells decreased expression of Atxn2, Insr, and Mc4r.
CONCLUSIONS—Association analysis suggests that variation
in A2BP1 inﬂuences obesity, and functional studies suggest that
A2BP1 could potentially affect adiposity via the hypothalamic
MC4R pathway. Diabetes 59:2837–2845, 2010
R
ecent large-scale genome-wide association stud-
ies (GWASs) have uncovered common variants
in several loci associated with obesity in multi-
ple populations (1–7). Most of these studies have
been done in populations of European ancestry. Addi-
tional GWASs in diverse ethnic groups could conﬁrm
previously identiﬁed obesity-associated genes, identify
novel ethnic-speciﬁc susceptibility genes, or identify eth-
nic-speciﬁc variation within a previously identiﬁed gene.
Several examples exist of common variation in a gene
contributing to obesity in one population but unique, rare
variation contributing to obesity in a different population.
For example, a common obesity-associated variant,
rs17782313, near MC4R has been widely replicated in
Europeans (3,5,6), but this same variant is nearly mono-
morphic for the Caucasian nonrisk allele (T allele) in
full-heritage Pima Indians, whereas rare coding variants in
MC4R, one of which is a novel frameshift mutation that
has not been reported in other populations, do contribute
to obesity in Pima Indians (8,9). Similarly, a common
obesity-associated variant in SIM1 has been reproducibly
associated with obesity in Native Americans but not
French Caucasians (10), whereas both rare deletions and
rare missense variants in SIM1 have been reported to be
associated with severe obesity in Caucasians (11–19).
To search for loci that may be important in determining
obesity in Pima Indians, we recently completed a GWAS
using the Affymetrix 100K genotyping array in a group of
413 nondiabetic full-heritage Pima Indians who were phe-
notyped for various measures of body composition includ-
ing percent body fat. Our most signiﬁcant association with
percent body fat was in the A2BP1 gene (rs10500331, P 
6.6  10
6), which encodes for the ataxin-2 binding
protein 1 (also known as FOX-1) and is involved in
tissue-speciﬁc alternative splicing (20). In addition to
containing RNA-binding motifs, A2BP1 also interacts with
ataxin-2 (ATXN2) (21), a protein thought to be involved
with RNA metabolism (22). ATXN2 has been implicated in
the neurodegenerative disorder spinocerebellar ataxia
type 2 (SCA2) (22), and hyperphagia and obesity are two
major clinical features reported in an Egyptian family with
SCA2 (23). Consistent with this observation, ataxin-2
knockout mice (Sca
/) are reported to be much more
obese than their wild-type littermates when both are fed a
high-fat diet (24,25). Therefore, based on the genetic
associations with percent body fat in our GWAS and the
obese phenotype of the Sca2
/ mouse, we studied A2BP1
as a potential candidate gene for human obesity.
RESEARCH DESIGN AND METHODS
Subjects and phenotypes. Descriptions of subjects used in the association
analyses are shown in Table 1. The GWAS sample consists of 413 nondiabetic,
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ized as inpatients in our Clinical Research Center and were informative for
quantitative traits related to obesity and diabetes, including percent body fat
and BMI. Some of these healthy, metabolically characterized subjects were
ﬁrst-degree relatives (413 subjects came from 264 sibships, 98 of whom
consisted of 2 siblings). Body composition was estimated by underwater
weighing until January 1996 and by dual-energy X-ray absorptiometry (DPX-1,
Lunar Radiation Corp, Madison, WI) thereafter. A conversion equation derived
from comparative analyses was used to make estimates of body composition
equivalent between the two methods (26). Associations were further assessed
in a full-heritage Pima Indian population-based sample (full-heritage Pima
population, n  3,234) derived from our longitudinal study of the etiology of
type 2 diabetes in the Gila River Indian Community in Central Arizona (27).
Most of the residents are Pima Indians, and many are related to one another.
The study includes biennial exams performed on individuals who provide
informed consent and include measurements of height, weight, and a 75-g oral
glucose tolerance test, where diabetes was diagnosed according to 1997
American Diabetes Association criteria. BMI was calculated as weight (kg)/
height (m
2). Analysis of BMI was restricted to all exams after the subjects
reached the age of 15 years (number of BMI measurements for all 3,234
subjects  15,722). Of these 3,234 subjects, 391 had been included in the
GWAS sample; therefore, to assess independent replication of the GWAS
associations, the 2,843 “nonoverlapping with GWAS” subjects were addition-
ally analyzed separately (number of BMI measurements for the 2,843 sub-
jects  13,751). Selected variants were genotyped in a second population-
based sample from our study of the Gila River Indian Community, which
consisted of all of the remaining longitudinally studied individuals who had a
BMI measure after the age of 15 years and a DNA sample available for
genotyping (n  2,531). In contrast to the full-heritage Pima sample, no
restrictions on heritage were applied for subjects in this second sample. The
subjects in this “mixed-heritage,” predominately Native American sample
(number of BMI measurements for 2,531 subjects  6,973) self-reported their
heritage as, on average, 1⁄2 Pima Indian and 3⁄4 Native American, with 59
individuals reporting no Native American heritage.
The Old Order Amish subjects (n  1,149) were from the Amish Family
Diabetes Study (28). The German school children consisted of 715 lean
subjects (control subjects, mean age  11.7  2.7 years, BMI between 16th
and 85th percentile) and 283 obese subjects (case subjects, mean age  11.5 
3.7 years, BMI  90th percentile) (29). French adult and children case/control
subjects from a GWAS for obesity have been described elsewhere (1). Brieﬂy,
case children were in the 97th age-and sex-speciﬁc percentile of BMI and had
evidence of familial obesity, and control children had a BMI  90th percentile.
Case adults had a BMI  40 kg/m
2 and evidence of familial obesity, and
control adults had a repeated BMI measure of 25 kg/m
2.
Genotyping for GWAS data. Subjects in the Pima GWAS were genotyped
using the Affymetrix 100K Human Mapping Array (Affymetrix, Santa Clara,
CA), and the methodology and quality control assessment have been de-
scribed previously (27). Published genotypic data across A2BP1 for the
French Caucasian adults and children were obtained from the Illumina Human
CNV370 Duo Array (1).
Sequencing and genotyping. DNA samples from 24 full-heritage Pima
Indians (12 obese/12 nonobese), who were not ﬁrst-degree relatives, were
sequenced to identify novel variants in A2BP1. Overlapping primers were
designed to sequence all 16 exons, 5- and 3-untranslated regions, and 2 kb of
the adjacent 5-region. Sequencing reactions were performed using a Big Dye
Terminator v1.1 cycle sequencing kit (Applied Biosystems, Foster City, CA)
and run on an automated DNA capillary sequencer (model 3730xl, Applied
Biosystems, Foster City, CA). Sequence information for the two novel variants
(A2BP1E3 and A2BP1E15) is provided at the bottom of supplementary Table
2, available in an online appendix at http://diabetes.diabetesjournals.org/cgi/
content/full/db09-1604/DC1. Linkage disequilibrium plots (D and r
2) were
generated using the Haploview program (Haploview, http//:www.broad.mit.
edu/mpg/haploview). Genotyping of the full-heritage Pima Indian and mixed-
heritage samples was performed using SNPlex (Applied Biosystems, Foster
City, CA) on an automated DNA capillary sequencer (model 3730xl, Applied
Biosystems, Foster City, CA). Selected variants were genotyped in the Old
Order Amish subjects (28) and German school children (29) using Taqman
genotyping assays (Applied Biosystems, Foster City, CA).
Statistical analysis. Statistical analyses were performed using the SAS
program of the SAS Institute (Cary, NC). For the GWAS data, linear regression
models were used to assess the association between genotype and percent
body fat or BMI, adjusting for covariates including age and sex. The logarithm
of BMI was used to reduce skewness. The generalized estimating equations
procedure was used to account for family membership because some subjects
were siblings. The method of genomic control was used to “correct” the P
values to their expected distribution. As described by Devlin et al., the mean

2 value was used to obtain the inﬂation parameter (	) and the corrected P
value was calculated from an F test with one degree of freedom in the
numerator and the number of markers in the denominator (30). The 	 was 1.14
for percent body fat and 1.16 for BMI. In addition, to provide a test that is
robust to stratiﬁcation (minimizes the false positive rate), a modiﬁcation of
the method described by Abecasis et al. was used where the associations are
partitioned into between- and within-family components (31); for the present
analyses, these components were represented, respectively, by the mean
number of risk alleles for the sibship and each individual’s departure from this
mean. For the longitudinally studied population-based samples, the associa-
tion between genotype and BMI was examined using all of the BMI measure-
ments for each individual measured after the age of 15 years. In these
analyses, a linear mixed model (PROC MIXED) was ﬁtted that included
genotype as a ﬁxed effect along with age, sex, birth year, diabetic status, and
duration of diabetes as covariates. For examinations at which an individual
did not have diabetes, the duration variable was coded as “0”; this approach
can account for the observation that BMI tends to decline after the diagnosis
of diabetes in this population (32). In addition, the model included random
effects representing sibship (to account for the fact that some individuals were
siblings) and individual (to account for multiple examinations within an
individual). An autoregressive correlation structure was used to model the
relationship between multiple examinations within an individual. To reduce
computation time, the random effects were estimated once in the absence of
genotypic effects and in subsequent analyses were held ﬁxed at the values
estimated in the full data. The likelihood ratio test was used to assess
statistical signiﬁcance. In the second population-based sample where many
individuals were of mixed-heritage, the individual estimate of Indian admix-
ture was also used as a covariate. These estimates were derived by using a
published method (33) from 32 markers selected for having large differences
in allele frequency between Native Americans and Caucasians (34). Tests for
TABLE 1
Subjects analyzed in association studies
Sample n (M/F)* Sample type Age (years) BMI
Percent
body fat
Full-heritage Pima Indian GWAS 413 (239/174) Metabolically studied inpatients 26.7  6.2† 34.0  7.5† 33.0  8.5†
Full-heritage Pima Indian population 3,234 (1,350/1,884) Population 36.9  14.6‡ 33.5  7.9‡ NA
Full-heritage Pima population
nonoverlapping with GWAS
2,843 (1,130/1,713) Population excluding GWAS 38.1  13.4‡ 33.4  7.8‡ NA
Caucasians
French adult case/control subjects 695 (147/548) Case subjects 44.1  12.0 47.3  7.6 NA
731 (181/550) Control subjects 55.2  8.2 21.8  1.9 NA
French children case/control
subjects
685 (310/375)
707 (332/375)
Case subjects
Control subjects
10.9  3.3
11.9  2.3
29.5  6.5
17.6  2.3
NA
NA
German school children
case/control subjects
283 (136/147)
715 (337/378)
Case subjects
Control subjects
11.6  3.6
11.7  2.7
30.5  6.2
18.1  2.1
NA
NA
Old Order Amish 1,149 (592/557) Family-based 49.6  16.8 30.0  4.7 NA
Mixed-heritage Native American 2,531 (1,120/1,411) Population 29.1  11.7 32.8  8.6 NA
Data are means  SD. NA indicates information on percent body fat was not available. *M, males; F, females. †Age, BMI, and percent body
fat at ﬁrst visit. ‡Age and BMI averaged over all visits.
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alleles on the phenotype. To assess the evidence for association when both
population-based samples of Native Americans were combined, the coefﬁ-
cients for the genotypic effect were combined and weighted by the inverse of
their variance estimates (35). P values were not adjusted for multiple
comparisons.
The association of BMI versus genotypes in the Amish sample was
performed using the generalized linear model after adjusting for age, sex, and
family membership. Comparison of genotype frequencies between the lean
and obese German school children case/control subjects were performed by
logistic regression analysis adjusted for age, sex, pubertal stage, and height.
Because parameter estimates for case subject–control subject and quantita-
tive trait analyses are not comparable, results were combined across studies
using Stouffer’s method of combining P values (36).
Tissue proﬁling for A2BP1. Primers located in exons 5 and 6 of the A2BP1
transcript (accession ID AF107203) were used to amplify cDNA from the
following human tissues: adipose, hypothalamus, pituitary (BD Marathon-
Ready cDNA; BD Bioscience/Clontech), brain, skeletal muscle, heart, fetal
liver, adult liver, kidney, pancreas (BD Human MTC Multiple Tissue cDNA
Panels I and II; BD Bioscience/Clontech), pancreatic islets (kindly provided by
Dr. Lorella Marcelli at Joslin Diabetes Center), and preadipocytes isolated
from Pima Indians. PCR products were sequenced to conﬁrm that they
encoded A2BP1.
Isolation of preadipocytes and synthesis of cDNA. Subjects for adipose
tissue biopsies were admitted as inpatients to our Clinical Research Center
and, after an overnight fast, underwent a subcutaneous abdominal needle
biopsy under local anesthesia with 1% lidocaine. Collagenase digestion of the
subcutaneous abdominal adipose tissue biopsy samples was done as previ-
ously described (37,38).
Cell culture and A2bp1 knockdown. Mouse N-41 hypothalamus cell line
(Cat. No. CLU121) was purchased from Cellutions Biosystems, Inc. (Burling-
ton, ON, Canada) and used within 10 passages of the original vial. Cells were
grown in Dulbecco’s modiﬁed Eagle’s medium (Invitrogen, Carlsbad, CA)
supplemented with 10% FBS (ATCC, Manassas, VA) and 20 mmol/l glucose
(EM Science, Cincinnati, OH) at 37°C with 5% CO2. Prior to small interfering
RNA (siRNA) transfection, N-41 cells were seeded in six-well plates at a
density of 
10
5 cells per well. For each transfection, 9 l of siPORT Amine
Transfection Agent (Silencer siRNA Transfection II Kit, Ambion, Austin, TX)
and A2bp1 siRNA were resuspended separately in 100 l of GIBCO Opti-MEM
I medium (Invitrogen, Carlsbad, CA). After incubating for 10 min at room
temperature, the siRNA and transfection agent mixtures were combined (total
200 l) and siRNA/transfection agent complexes were allowed to form for 10
min. After the 10 min incubation, the 200 l transfection mixture was added
to each well, and after 8–24 h, the media was replaced. The transfected cells
were incubated for 48 h and then harvested for RNA extraction. SiRNA (sense,
5-GAUUUGGUUUCGUAACUUUtt-3 and antisense, 5-AAAGUUACGAAAC
CAAAUCcc-3; assay ID si114129) targeting the mouse A2bp1 transcript and
negative control (scrambled) siRNA (assay ID 4618G) were purchased from
Ambion (Austin, TX). Total RNA was extracted from the transfected N-41 cells
using an RNeasy Mini Kit (Qiagen, Valencia, CA). To remove any residual
DNA, the puriﬁed RNA was treated with DNase using an RNase-free DNase set
(Qiagen, Valencia, CA). First-strand cDNA was synthesized using an Ambion
RT-for-PCR kit (Austin, TX). Gene expression levels for mouse A2bp1, Atxn2,
Insr, Mc4r, Lepr, and Npy1r were quantiﬁed by real-time PCR using prede-
signed gene expression assays (assay IDs: A2bp1, Mm00480615_m1; Atxn2,
Mm00485932_m1; Insr, Mm00439693_m1; Mc4r, Mm00457483_s; Lepr,
Mm00440181_m1; and Npy1r, Mm00650798_g1; Applied Biosystems, Foster
City, CA). Real-time PCR was performed using an ABI-7700 sequence detec-
tion system (Applied Biosystems, Foster City, CA). Assays were performed in
replicates of six, and the mean values were used to calculate expression levels
using the relative standard curve method. Glyceraldehyde-3-phosphate dehy-
drogenase (Gapdh, assay ID Mm03302249_g1, Applied Biosystems, Foster
City, CA) was used as the endogenous control to obtain normalized values.
Each experiment was independently repeated three times. Student t test was
used to compare the means for cells transfected with A2bp1 siRNA with those
transfected with control siRNA.
RESULTS
Association analyses among 413 metabolically character-
ized, nondiabetic full-heritage Pima Indians who had been
genotyped using the Affymetrix 100K Human Mapping
Array identiﬁed rs10500331 as the strongest genome-wide
signal for percent body fat (P  6.6  10
6 after genomic
control, adjusted for age and sex; supplementary Fig. 1
and designated in bold in supplementary Table 1, available
in an online appendix). Among these 413 GWAS subjects,
rs10500331 was also associated with BMI (P  8.1  10
5
after genomic control, adjusted for age and sex; Table 2
and supplementary Table 1). To validate this GWAS asso-
ciation, rs10500331 was genotyped in a longitudinally
studied, full-heritage Pima Indian population-based sam-
ple (n  3,234) where individuals had multiple measures
of BMI (description of the subjects is given in Table 1).
Rs10500331 was associated with BMI in this full-heritage
Pima Indian population sample (P  1.9  10
7) and
remained signiﬁcant after excluding all subjects that over-
lapped with the initial GWAS study (nonoverlapping with
GWAS full-heritage sample, n  2,843; P  1.9  10
5)
(Table 2). Although independently replicated, these asso-
ciations do not quite meet the proposed threshold for
genome-wide signiﬁcance of P  7  10
8 (39). To further
substantiate these associations by ruling out potential
confounding effects of population stratiﬁcation, we used
the family structure of these samples and performed a
within-family analysis, where rs10500331 was again asso-
ciated with BMI in the initial GWAS sample (P  5.3 
10
2, supplementary Table 1), the entire full-heritage Pima
Indian population sample, and the population sample after
TABLE 2
Association of rs10500331 and rs12924838 with BMI or obesity in the populations described in Table 1
rs10500331 (C/T)* rs12924838 (G/A)*
Population sample n AF (T)† PZ AF (A)† PZ
Full-heritage Pima Indian GWAS 413 0.49 8.1  10
5 3.94 0.50 3.0  10
4 3.61
Full-heritage Pima Indian population 3,234 0.49 1.9  10
7 5.20 0.50 3.3  10
6 4.65
Full-heritage Pima Indian population
nonoverlapping with GWAS 2,843 0.49 1.9  10
5 4.28 0.50 4.2  10
5 4.10
French adult case/control subjects 1,426 0.13 0.98 0.025 0.27 0.03 2.20
French children case/control subjects 1,392 0.13 0.96 -0.06 0.27 0.90 0.13
German school children case/control
subjects 998 0.12 0.80 0.26 ND ND ND
Old Order Amish 1,149 0.11 0.80 0.26 0.29 0.12 1.56
All Europeans‡ 4,965 – 0.81 0.24 – 0.02 2.25
P values were determined using the additive model. *Bold allele is deﬁned as the risk allele (associated with higher BMI) based on the Pima
GWAS data. Z scores are calculated from the one-sided P value for the alternate hypothesis that the association is in the same direction as
that observed in the Pima GWAS. †AF, allele frequency. ‡Combined analysis for all Europeans was performed by combining the P values by
Stouffer’s method (i.e., combining the Z scores). LD between the two variants; Pima Indians D0.95, r
2  0.95 and Caucasians D0.83,
r
2  0.25. ND indicates not determined.
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3
and 3.2 10
2, respectively) (supplementary Table 2).
Rs10500331 maps within intron 1 of the A2BP1 gene,
and several other variants within A2BP1 also showed
signiﬁcant associations with percent body fat and BMI in
the GWAS study (supplementary Table 1). To directly
examine A2BP1 as a candidate gene for obesity in Pima
Indians, all exons and 2 kb of the upstream region of this
gene were sequenced in 24 Pima Indians selected for being
obese or nonobese. Twelve variants were identiﬁed of
which two were rare novel substitutions (frequencies of
the minor alleles  0.03 and 0.09; sequences are provided
in supplementary Table 2). An additional 108 variants
spanning A2BP1 were then selected for genotyping in the
full-heritage Pima Indian population sample (n  3,234).
The 108 variants consisted of 66 tag SNPs (minor allele
frequency  0.15 and a pairwise r
2  0.8) from our
previous 100K GWAS, 34 variants selected from our ongo-
ing 1M GWAS, and 8 variants identiﬁed by sequencing
including the two novel variants. Linkage disequilibrium
plots (r
2 and D) for all 109 variants (including rs10500331)
are shown in supplementary Fig. 2, available in an online
appendix. Associations for all 109 variants with BMI, using
both general and within-family analytical models, are
shown for the entire full-heritage Pima Indian population
sample to preserve power (n  3,234), as well as for the
n  2,843 nonoverlapping with GWAS sample (supplemen-
tary Table 2). Several variants displayed modest associa-
tions (general and within-family analyses) in both samples;
however, none of the associations was as strong as that for
rs10500331.
Two variants, rs10500331 and rs12924838, which are in
high linkage disequilibrium in full-heritage Pima Indians
but not Caucasians (D0.96, r
2  0.92 in Pima and D
0.83, r
2  0.25 in Caucasians; Fig. 1B and C) were
signiﬁcantly and reproducibly associated with BMI in Pima
Indians (Table 2). These variants were further evaluated in
four additional cohorts of European ancestry including
French adult case/control subjects (1), French children
case/control subjects (1), Amish families (28), and German
school children case/control subjects (29). There was no
evidence of association of rs10500331 with obesity in the
French adult or children case/control subjects nor was
there an association of this variant with BMI in the Amish
or German school children case/control subjects (Table 2);
however, rs12924838 was nominally associated with obe-
sity in the French adult case/control subjects (P  0.03)
and when all of the European data were combined (n 
4,965, P  0.02) (Table 2). Although neither rs10500331 nor
rs12924838, which both map within intron 1 of A2BP1,
appear to be convincingly associated with obesity or BMI
in these European cohorts, a prior GWAS for severe
obesity using case/control subjects of either French chil-
dren or French adults identiﬁed several other variants
within intron 1 of A2BP1 that were signiﬁcantly associated
with severe obesity (1). In the French children case/
control subjects stage 1 samples, rs8054147 displayed the
strongest association with obesity (P  9.2  10
6, Fig. 2),
whereas in the French adult case/control subjects stage 1
samples, rs4786847 had the strongest association (P 
1.9  10
10, Fig. 2). The striking association of rs4786847
with obesity was speciﬁc for the stage 1 French adult
sample. For the stage 2 sample, which included 519 obese
children and 566 lean young adults of French origin, 377
obese children and 731 lean children of German origin, 135
obese adults and 794 lean adults of French origin, 1,036
obese adults and 320 randomly selected adults of Swiss
origin, a general population of 5,291 Finnish children, and
a general population of 4,417 French adults, the associa-
tion of rs4786847 with obesity or BMI was nominal (all
stage 2 children P  0.005, all stage 2 adults P  0.76,
entire stage 2 sample P  0.03) (1).
To determine whether the associations observed with
BMI in the Pima Indians represent a signal speciﬁc for
Native Americans, ﬁve variants (rs9302818, rs10500331,
rs8052357, rs12924838, and rs1946127) with the strongest
associations with BMI in the full-heritage Pima Indians,
and one variant (rs4786847) most strongly associated with
BMI in the French adults, were genotyped in a second
population-based sample of 2,531 individuals who were
predominately Native Americans of mixed-heritage. Al-
though none of the ﬁve variants most strongly associated
with BMI in the full-heritage Pima Indians replicated in
this mixed-heritage Native American sample, rs4786847,
which had the strongest association in the French adult
case/control subjects (P  1.9  10
10), modestly repli-
cated (P  0.02, Table 3). Combining the full-heritage Pima
Indian and mixed-heritage Native American population-
based samples provided strong associations with BMI for
all six variants; however, only the association with
rs4786847 was strengthened from the combination of the
two samples, whereas the other associations were solely
due to the full-heritage Pima Indian sample (Table 3).
European genotypic data were additionally available on
three of these variants, making an “all-sample” (i.e., sub-
jects in Table 1) analysis possible. All-sample P values for
these three variants ranged from 0.02 to 0.0002 (Table 3),
where signiﬁcance was largely derived from a single
sample.
A2BP1 is expressed in various tissues including hypo-
thalamus, a major tissue in body weight regulation (Fig. 3),
and it has also been reported to be expressed in brain,
heart, and skeletal muscle tissue (21). To functionally
investigate a possible role of A2BP1 in hypothalamic body
weight regulation, siRNA that target the mouse A2bp1
gene were used to knockdown A2bp1 expression in a
mouse embryonic hypothalamic cell line (N-41) and mRNA
levels of ﬁve target genes were assessed by RT-PCR. These
ﬁve genes included Atxn2, which encodes the binding
partner of A2bp1 and has been implicated in human
hyperphagia (23), and four additional genes, Insr, Lepr,
Npy1r, and Mc4r, known to function in key pathways of
central regulation of energy balance and known to be
expressed in N-41 cells. RT-PCR of A2bp1 was also used to
assess the efﬁciency of the siRNA knockdown.
We found that a 75% reduction in A2bp1 expression in
the N-41 cells led to a 53, 60, and 75% decrease in gene
expression levels for Atxn2, Insr, and Mc4r, respectively,
whereas expression levels for Lepr and Npy1r were
largely unaffected (Fig. 4).
DISCUSSION
The associations between variants in A2BP1 with both
percent body fat and BMI in our 100K GWAS and the
evidence for association of these variants with longitudi-
nally measured BMI in a large population-based sample of
full-heritage Pima Indians, along with the obese pheno-
types observed with Atxn2 knockout mice (24,25) and
high expression levels of A2BP1 in the hypothalamus,
leads us to speculate that A2BP1 has a role in body weight
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2840 DIABETES, VOL. 59, NOVEMBER 2010 diabetes.diabetesjournals.orgregulation. However, the highly signiﬁcant associations
obtained with different variants in each of the Pima Indian,
French adult, and French children studies is inconsistent
with a single common variant giving rise to this phenotype.
Among populations representing different ethnicities, lack
of reproducibility with a speciﬁc variant may be due to the
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linkage disequilibrium patterns between ethnic groups
(40). Pezzolesi et al. describe a similar pattern where
different variants across the same locus (ELMO1)i n
different ethnic groups, Caucasians (41), African-Ameri-
cans (42), and Japanese (43), are associated with diabetic
nephropathy (41). They suggest that this allelic heteroge-
neity is probably the result of different ancestral genetic
backgrounds and propose that rare variants in ELMO1
may be common to each ethnic group and are being tagged
by the common variants found in the individual studies
(41). This concept, however, cannot explain strong asso-
ciations of different variants in French adults and in
French children. Another hypothesis more consistent with
our observations is that strong, yet distinct, associations
within a region of a biologically relevant gene would be
observed if there are multiple rare causative variants that
can occur within a single ethnic group. These rare vari-
ants, all of which could affect a potential functionally
important region (e.g., intron 1 of A2BP1), may be more
highly represented by chance in one sample set than in
another and, thus, provide association signals with differ-
ent tag SNPs in one group of individuals than in another.
Deep resequencing across intron 1 of A2BP1 in each of the
different populations may be the best approach to test this
hypothesis. At present, the costs of deep resequencing in a
large number of subjects make this line of investigation
difﬁcult. Therefore, we chose to investigate the function of
A2BP1 directly based on the current association data and
the observation that atxn2
/ mice become obese.
A2BP1 is a RNA-binding protein involved in regulating
tissue-speciﬁc alternative splicing by binding the RNA
cis-regulatory element UGCAUG (20). A2BP1 binding to
UGCAUG elements downstream of the exon enhances
exon inclusion, while binding to UGCAUG elements up-
stream of the exon represses exon inclusion (20). The
UGCAUG motif is highly enriched in brain-speciﬁc intronic
regions ﬂanking exons and alternative exons (44). A recent
genome-wide survey for the UGCAUG element identiﬁed
1,103 genes with at least one predicted UGCAUG element.
Included in this gene list were A2BP1 (ﬁve elements),
ATXN2 (two elements), and INSR (two elements) (44). In
addition to binding the UGCAUG splicing motif, A2BP1 is
a binding partner for the ATXN2 protein (21), which also
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and is thought to be involved in mRNA degradation and
regulating translation (45,46).
In the human hypothalamus, LEPR and INSR sense the
peripheral leptin and insulin signals to control food intake
and energy homeostasis through POMC-MC4R and NPY-
Y1R pathways. Central nervous system deﬁciencies of
these pathways are known to affect energy homeostasis
and result in severe obesity (47,48). After knockdown of
A2bp1 in the N-41 mouse embryonic hypothalamic cells,
we observed a decrease in both INSR and MC4R expres-
sion. Knockdown of A2BP1 also resulted in a decrease in
Atxn2 gene expression, and it has been shown by others
that Atxn2 knockout mice become obese (24,25). How-
ever, the mechanism whereby deﬁciency of A2BP1 expres-
sion leads to a decrease in mRNA levels for these three
genes is unknown. Because both ATXN2 and INSR have
predicted UGCAUG splicing elements (44), mRNA splicing
for the two genes may be affected by a decrease in A2BP1,
leading to unstable transcripts that are subsequently de-
graded. Unlike ATXN2 and INSR, the transcript for Mc4R
codes for only one exon and does not appear to contain
binding sites for A2BP1. Therefore, instead of affecting
mRNA stability, the reduction in A2BP1 may result in the
decrease of Mc4R indirectly by affecting some transcrip-
tional regulatory protein involved in the expression of
Mc4R.
In conclusion, GWAS data in Pima Indians and French
Caucasians suggest that multiple variants in A2BP1 may
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FIG. 3. Expression proﬁle for A2BP1 in different human tissues.
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diabetes.diabetesjournals.org DIABETES, VOL. 59, NOVEMBER 2010 2843exist that contribute to human obesity, and A2bp1 knock-
down studies suggest that deﬁciency of A2bp1 could play
a role in the hypothalamic regulation of feeding. However,
deep resequencing of A2BP1 and further in vivo studies
are necessary to conﬁrm the biological role of this gene in
the pathogenesis of obesity.
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